How Much Does Testosterone Enanthate Cost in Maryland in 2026?

Retail Cash Prices Across Maryland Pharmacies

The average cash-pay price for testosterone enanthate at Maryland retail pharmacies sits at $70 per month in 2026, based on a standard weekly injection protocol of 100 to 200 mg intramuscularly. This figure represents generic testosterone enanthate (200 mg/mL vials), which accounts for the majority of dispensed prescriptions statewide.

Prices vary by pharmacy chain and location. Large chains in Baltimore, Bethesda, and Columbia tend to cluster between $55 and $90 per month without insurance. Independent pharmacies occasionally offer competitive pricing, particularly those in less densely populated areas of the Eastern Shore or Western Maryland. The manufacturer list price remains $120 per month, but few patients pay this amount given generic competition and discount programs.

A 1 mL vial (200 mg/mL) typically provides one to two weeks of therapy depending on prescribed dose. A 5 mL multi-dose vial offers better per-unit economics: patients filling a 5 mL vial every 5 to 10 weeks often pay $30 to $50 per fill, translating to roughly $45 to $65 per month. The T-Trials (N=790), published in the New England Journal of Medicine, established the clinical framework for testosterone therapy dosing that informs these standard regimens 1.

Pharmacy benefit managers negotiate different rates with each chain, so the same NDC code can show price differences of 40% between two pharmacies three miles apart. Checking multiple locations or using a price-comparison tool before filling is practical advice that saves Maryland patients $15 to $30 per fill on average.

Maryland Medicaid Coverage for Testosterone Enanthate

Maryland Medicaid covers testosterone enanthate for male hypogonadism with prior authorization. The process requires documented low serum testosterone (typically two morning readings below 300 ng/dL), a clinical diagnosis of hypogonadism, and prescriber attestation that the patient has signs or symptoms consistent with testosterone deficiency.

The prior authorization form routes through Maryland's Medicaid pharmacy program. Approval turnaround averages 3 to 5 business days. Once approved, the patient pays $0 to $3 per fill depending on their specific Medicaid plan tier. Maryland HealthChoice MCOs (managed care organizations) such as CareFirst Community Health Plan, Priority Partners, and Jai Medical Systems all follow the state PA criteria, though individual MCOs may have slightly different formulary placement.

The Endocrine Society's 2018 Clinical Practice Guideline recommends testosterone therapy for men with symptomatic testosterone deficiency confirmed by reliable assays 2. Maryland Medicaid aligns its PA criteria with this guideline, requiring both biochemical and clinical evidence before approval.

Denials most commonly occur when only one testosterone level is submitted, when the morning draw timing is not documented, or when the diagnosis code does not match (ICD-10 E29.1 for primary hypogonadism or E23.0 for secondary). Appealing with corrected documentation succeeds in the majority of cases.

Commercial Insurance Coverage in Maryland

Most commercial health plans in Maryland cover generic testosterone enanthate on formulary Tier 1 or Tier 2. CareFirst BlueCross BlueShield, the state's dominant commercial insurer, places testosterone enanthate on its generic injectable tier with a typical copay of $10 to $30 per fill after meeting the specialty drug threshold.

UnitedHealthcare, Aetna, and Cigna plans sold through the Maryland Health Benefit Exchange (the state ACA marketplace) similarly cover testosterone enanthate. Prior authorization requirements vary: some commercial plans require PA only for patients under 40, while others require it universally. The American Urological Association's 2018 guideline on testosterone deficiency supports treatment in symptomatic men with confirmed low levels regardless of age 3.

Federal employee plans (FEHB), which cover a substantial portion of Maryland's workforce given proximity to Washington, D.C., generally include testosterone enanthate with standard copays. The BlueCross BlueShield Federal Employee Program and GEHA both list it as a covered injectable medication.

Patients with high-deductible health plans (HDHPs) still pay full negotiated price until meeting their deductible, which can mean $50 to $80 out-of-pocket per fill for the first several months of the year. Pairing an HDHP with a manufacturer savings card or GoodRx-style coupon bridges this gap.

Compounded Testosterone Enanthate in Maryland

Compounded testosterone enanthate is legal and available in Maryland through licensed 503A pharmacies. These pharmacies compound patient-specific prescriptions under a valid prescription from a licensed provider. The average price for compounded testosterone enanthate in Maryland runs approximately $80 per month.

Maryland's Board of Pharmacy regulates 503A compounding pharmacies under COMAR 10.34.19. Compounding pharmacies must hold a valid Maryland pharmacy permit and comply with USP 797 sterile compounding standards. Several compounding pharmacies operate in the Baltimore-Washington corridor, and others ship within Maryland under state-specific regulations.

Why might compounded testosterone cost more than generic retail? The answer is nuanced. While some patients pay more for compounded preparations, others seek compounding for specific concentrations (e.g., 250 mg/mL for smaller injection volumes), combination formulations, or preservative-free options not available commercially. Some patients also use compounded testosterone in grape seed oil or sesame oil carrier bases depending on allergy profiles.

The FDA's guidance on compounded testosterone products requires that 503A pharmacies compound only in response to individual prescriptions and not produce large batches for office use without a 503B outsourcing facility designation. Maryland patients should verify their compounding pharmacy holds current state licensure.

Telehealth Prescribing of Testosterone Enanthate in Maryland

Maryland permits telehealth prescribing of testosterone enanthate. Yes, fully legal. The Ryan Haight Act requires that controlled substance prescriptions via telehealth include at least one legitimate medical evaluation, which can be conducted by video in Maryland per state telehealth parity laws effective since 2021.

Maryland House Bill 123 (2021) and subsequent regulatory updates established that telehealth encounters satisfy the prescriber-patient relationship requirement for controlled substances when conducted via synchronous audio-video communication. This means Maryland residents can receive a testosterone enanthate prescription from a licensed Maryland prescriber (or a prescriber licensed in Maryland via interstate telehealth compact) without an in-person visit.

Telehealth TRT clinics operating in Maryland must still comply with DEA registration requirements and Maryland Board of Physicians oversight. The prescriber must hold an active Maryland medical license or practice under a valid interstate compact agreement. Lab work (serum testosterone, CBC, PSA, lipid panel) must be completed and reviewed before prescribing, per standard of care outlined in the Endocrine Society guideline 2.

Typical telehealth TRT consultation costs in Maryland range from $99 to $199 for the initial visit and $75 to $150 for follow-ups every 3 to 6 months. Some telehealth platforms bundle consultation fees with medication costs at $150 to $250 per month all-inclusive.

Discount Programs and Savings Strategies

Several pathways reduce testosterone enanthate costs for Maryland patients. Manufacturer savings cards, pharmacy discount programs, and strategic pharmacy selection all contribute to lower out-of-pocket spending.

GoodRx, RxSaver, and similar aggregator platforms show Maryland-specific pricing that often beats uninsured cash rates by 20% to 50%. A GoodRx coupon for a 5 mL vial of testosterone enanthate 200 mg/mL frequently shows prices between $35 and $55 at major Maryland chains, effectively reducing monthly cost to $25 to $45 depending on prescribed dose.

Manufacturer copay cards exist for branded testosterone products but have limited utility for generic enanthate specifically. However, patients prescribed brand-name Delatestryl (testosterone enanthate) may access manufacturer assistance programs that cap monthly copays at $25 to $50.

Mark Cuban's Cost Plus Drugs (costplusdrugs.com) ships to Maryland and lists testosterone enanthate at its acquisition cost plus a flat markup and dispensing fee. Pricing through this model typically runs $8 to $15 for a 5 mL vial before shipping.

The 340B Drug Pricing Program benefits patients who receive care at federally qualified health centers (FQHCs) in Maryland. Facilities like Total Health Care in Baltimore, Chase Brexton Health Care, and Community Health Centers of Maryland participate in 340B pricing, which can reduce testosterone enanthate costs to $5 to $20 per fill for eligible patients.

Monitoring Costs Beyond the Medication

Testosterone enanthate therapy requires ongoing lab monitoring that adds to total treatment cost. The Endocrine Society recommends checking serum testosterone at 3 to 6 months after initiation, then annually, along with hematocrit, PSA (for men over 40), and lipid panels 2.

In Maryland, a basic testosterone level lab draw through Quest Diagnostics or LabCorp costs $30 to $75 without insurance. A comprehensive TRT monitoring panel (total testosterone, free testosterone, estradiol, CBC with differential, comprehensive metabolic panel, lipid panel, PSA) runs $150 to $300 out-of-pocket.

Insurance-covered labs typically cost $0 to $50 in copays. Maryland Medicaid covers diagnostic labs at no cost to the patient. For cash-pay patients, direct-to-consumer lab services like Walk-In Lab or Ulta Lab Tests offer Maryland locations with pricing 40% to 60% below hospital outpatient lab fees.

Annual total cost of testosterone enanthate therapy in Maryland, including medication, labs, and provider visits, ranges from approximately $900 to $2,400 for cash-pay patients and $200 to $600 for insured patients with favorable formulary placement.

Comparing Maryland to Neighboring States

Maryland's average $70 per month cash price for testosterone enanthate falls in the mid-range for the Mid-Atlantic region. Virginia averages $65 per month, Pennsylvania $75, Delaware $68, and Washington, D.C. $85. The higher D.C. pricing reflects elevated pharmacy operating costs in the District.

Maryland's Medicaid program is more accessible than some neighboring states for testosterone coverage. Virginia Medicaid also covers with PA, but West Virginia's fee-for-service Medicaid has more restrictive quantity limits. Pennsylvania's Medicaid program covers testosterone enanthate with similar PA requirements to Maryland's.

For patients near state borders (common in the Baltimore-Washington corridor), filling prescriptions in the state with the lowest price is legal, though controlled substance prescriptions must comply with both the prescribing state and dispensing state regulations. A Maryland prescription filled at a Virginia pharmacy is permissible provided both state pharmacy laws are satisfied.

The T-Trials demonstrated that testosterone therapy improved sexual function, physical function, and vitality in men 65 and older with confirmed low testosterone 1. These benefits apply regardless of geographic location, but access and cost vary meaningfully by state policy. Maryland's combination of Medicaid coverage, legal telehealth prescribing, and 503A compounding access positions it favorably relative to more restrictive jurisdictions.

How to Get the Lowest Price in Maryland

Start with insurance verification. Call the number on the back of your insurance card and ask: "Is testosterone enanthate on formulary, and does it require prior authorization?" If yes to PA, have your prescriber submit it proactively before your first fill.

If uninsured or facing a high deductible, compare prices across at least three pharmacies using a discount aggregator. Consider a 5 mL multi-dose vial over 1 mL single-use vials for better per-unit pricing. Ask your prescriber to write the prescription for the larger vial size.

For Maryland Medicaid beneficiaries, ensure your prescriber uses the correct ICD-10 code (E29.1 or E23.0) and submits two documented morning testosterone levels below 300 ng/dL with the PA request. First-pass approval rates exceed 80% when documentation is complete.

Patients using telehealth platforms should compare all-inclusive monthly pricing against the sum of separate provider visit fees plus pharmacy costs. For some patients, paying $70 per month for medication at a local pharmacy plus $30 per month amortized telehealth visit cost ($180 every 6 months) totals $100 per month, which may be less than an all-inclusive telehealth bundle at $200 per month.

The FDA-approved labeling for testosterone enanthate specifies 50 to 400 mg intramuscularly every 2 to 4 weeks 4. Most current clinical practice favors weekly dosing of 100 to 200 mg for more stable serum levels, and Maryland prescribers overwhelmingly follow this weekly protocol.